Global Market Study on Active Pharmaceutical Ingredients

Jun 2017| PMR280A| Persistence Market Research

Report Highlights

An active pharmaceutical ingredient is a substance or a combination thereof used in a pharmaceutical product for providing direct access to the diagnosis, prevention, cure, or treatment of diseases or to have a direct impact in correcting, modifying, or restoring physiological functions in humans. Persistence Market Research has studied the global active pharmaceutical ingredients market in its report titled “Active Pharmaceutical Ingredients Market: Global Industry Analysis and Forecast, 2017 – 2025’’. The report includes revenue of the API manufacturers i.e. for both outsourced and in-house manufacturing. However, the report doesn’t consider API revenue that has not been mentioned herein.

Active Pharmaceutical Ingredients Market: Taxonomy

Region

  • North America
  • Latin America
  • Europe
  • APAC
  • RoW

API Type

  • Small Molecules
  • Controlled Substances
  • Natural Opioids
  • Semi-synthetic/Synthetic Opioids
  • Non-Controlled Substances
  • NSAIDs
  • Anti-infective
  • Antimicrobial
  • Oral anti-diabetics
  • Anti-hypertensive
  • Others
  • HPAPI
  • Peptides & Oligonucleotides
  • Carbohydrate Drugs
  • Steroidal Drugs

Certain assumptions have been made and a few acronyms have been used to prepare the active pharmaceutical ingredients market report. These have been adequately explained in a section that readers can acquaint themselves with to ensure that they understand the active pharmaceutical ingredients market with all of its nuances and technicalities.

One-of-a-kind research methodology used to prepare all research reports

The research methodology adopted by PMR to create reports such as the active pharmaceutical ingredients market report is world class. The team of diverse, knowledgeable analysts begin their study with rigorous primary and secondary research in the active pharmaceutical ingredients market. A market player list that includes each node of the value chain is devised and a questionnaire that assists in the extraction of all the required data is prepared. After the information has been gathered, it is exhaustively validated using the triangulation method that combines the opinions of PMR experts with both primary and secondary research data. The final data is thoroughly scrutinized to obtain all the necessary insights concerning the active pharmaceutical ingredients market.

The active pharmaceutical ingredients market is marked by cutthroat competition and it is challenging but not impossible for any new entrants seeking to enter this lucrative market. Potential stakeholders are highly advised to refer to the competition landscape chapter of the active pharmaceutical ingredients market report. Here, PMR has profiled several prominent organizations active in the global active pharmaceutical ingredients market. The key players for small molecule API CDMO, Peptide API, Oligonucleotide API, Steroid API, Carbohydrate API, HPAPI, and controlled substances have each been analyzed in a different section. It is possible to carry out an in-depth competition SWOT analysis and potential entrants can decide which segment they wish to target based on their inherent strengths and the weaknesses of the immediate competition.

It is not surprising that there is a heavy regulatory oversight in a market as critical to human life as the active pharmaceutical ingredients market. A highly important section of the active pharmaceutical ingredients market report has specifically spoken about the major deals and regulations that pertain to API CDMO. It is followed by the drug pipeline analysis of Oligonucleotides, Peptides, Steroidal drugs, and High Potency API Drugs. The primary respondents by each region and their outlooks follow. The global active pharmaceutical ingredients market has been divided into five broad geographic regions viz. APAC, RoW, Europe, Latin America, and North America; each of which has its own section in the active pharmaceutical ingredients market report. The report provides the market value share and BPS analysis of the largest regional markets and also gives the market attractiveness on a country basis. Key trends and regulations that pertain to a specific region or country within that region complete this informative section.

The active pharmaceutical ingredients market report has a preface at the outset that is a brief glance at the active pharmaceutical ingredients market. It is closely related to (and followed by) the market definition as well as the taxonomy of the active pharmaceutical ingredients market. PMR analysts have studied the active pharmaceutical ingredients market for a period of eight years from 2017 to 2025 and have formed their opinions and recommendations based on current and future anticipated trends in the active pharmaceutical ingredients market. These have been detailed in the form of geographic regions and segments to target with a differentiating strategy to stand above all others in the active pharmaceutical ingredients market.

The market dynamics of a market as volatile as the active pharmaceutical ingredients market cannot be overlooked. The drivers, restraints, opportunities, and trends that are predicted to have an outsized impact on the active pharmaceutical ingredients market are highlighted in this section and report readers would do well to peruse them to make critical decision-making that little bit easier.

  • Table 1 : Global Pharmaceutical Market Indicators
  • Table 2 : Active Pharmaceutical Ingredient Market Value (US$ Bn), by API Type, 2011-2025
  • Table 3 : North America Active Pharmaceutical Ingredient Market Value (US$ Bn), by Region, 2011�2025
  • Table 4 : North America Active Pharmaceutical Ingredient Market Value (US$ Bn), by API Type, 2011�2025
  • Table 5 : North America Active Pharmaceutical Ingredient Market Value (US$ Bn), by Country, 2011�2025
  • Table 6 : Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn), by API Type, 2011�2025
  • Table 7 : Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn), by Country, 2011�2025
  • Table 8 : Europe Active Pharmaceutical Ingredient Market Value (US$ Bn), by API Type, 2011�2025
  • Table 9 : Europe Active Pharmaceutical Ingredient Market Value (US$ Bn), by Country, 2011�2025
  • Table 10 : Asia Pacific Active Pharmaceutical Ingredient Market Value (US$ Bn), by API Type, 2011�2025
  • Table 11 : Asia Pacific Active Pharmaceutical Ingredient Market Value (US$ Bn), by Country, 2011�2025
  • Table 12 : Rest of World Active Pharmaceutical Ingredient Market Value (US$ Bn), by API Type, 2011�2025
  • Table 13 : Rest of World Active Pharmaceutical Ingredient Market Value (US$ Bn), by Country, 2011�2025
  • Figure 1 : Global Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth Forecast, 2014�2024
  • Figure 2 : Peptide Drug Pipeline Analysis
  • Figure 3 : Peptide Drug Pipeline Analysis by Companies,
  • Figure 4 : Steroidal Drug Pipeline Analysis by Developmental Phase, 2016
  • Figure 5 : Steroidal Drug Pipeline Analysis
  • Figure 6 : High Potency Drug Pipeline Analysis by Developmental Phase, 2016
  • Figure 7 : High Potency Drug Pipeline Analysis
  • Figure 8 : Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by API Type, 2017 & 2025
  • Figure 9 : Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by API Type, 2015�2025
  • Figure 10 : Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2011�2016
  • Figure 11 : Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2016�2025
  • Figure 12 : Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2011�2016
  • Figure 13 : Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2016�2025
  • Figure 14 : Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2011�2016
  • Figure 15 : Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2016�2025
  • Figure 16 : Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2011�2016
  • Figure 17 : Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2016�2025
  • Figure 18 : Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2011�2016
  • Figure 19 : Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2016�2025
  • Figure 20 : Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2011�2016
  • Figure 21 : Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2016�2025
  • Figure 22 : Active Pharmaceutical Ingredient Market Attractiveness Analysis, by Product Type, 2016�2025
  • Figure 23 : Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by API Type, 2017 & 2025
  • Figure 24 : Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by API Type, 2016�2025
  • Figure 25 : North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2011�2016
  • Figure 26 : North America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), 2016�2025
  • Figure 27 : Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2011�2016
  • Figure 28 : Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2016�2025
  • Figure 29 : Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2011�2016
  • Figure 30 : Europe Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), 2016�2025
  • Figure 31 : APAC Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2011�2016
  • Figure 32 : APAC Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2016�2025
  • Figure 33 : RoW Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), 2016�2025
  • Figure 34 : RoW Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2016�2025
  • Figure 35 : Global Active Pharmaceutical Ingredients Market Attractiveness Index, 2016-2025
  • Figure 36 : North America Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by Country, 2016 & 2025
  • Figure 37 : North America Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by Country, 2016�2025
  • Figure 38 : North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2011�2016
  • Figure 39 : North America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2016�2025
  • Figure 40 : North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2011�2016
  • Figure 41 : North America Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2016�2025
  • Figure 42 : North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2011�2016
  • Figure 43 : North America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2016�2025
  • Figure 44 : North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2011�2016
  • Figure 45 : North America Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2016�2025
  • Figure 46 : North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2011�2016
  • Figure 47 : North America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2016�2025
  • Figure 48 : North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2011�2016
  • Figure 49 : North America Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2016�2025
  • Figure 50 : North America Active Pharmaceutical Ingredients Market Attractiveness Index, 2016-2025
  • Figure 51 : Latin America Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by Country, 2017 & 2025
  • Figure 52 : Latin America Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by Country, 2016�2025
  • Figure 53 : Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2011�2016
  • Figure 54 : Latin America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2016�2025
  • Figure 55 : Latin America Active Pharmaceutical Ingredient Historic Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2011�2016
  • Figure 56 : Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2016�2025
  • Figure 57 : Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2011�2016
  • Figure 58 : Latin America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2016�2025
  • Figure 59 : Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2011�2016
  • Figure 60 : Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2016�2025
  • Figure 61 : Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2011�2016
  • Figure 62 : Latin America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2016�2025
  • Figure 63 : Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2011�2016
  • Figure 64 : Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2016�2025
  • Figure 65 : Latin America Active Pharmaceutical Ingredients Market Attractiveness Index, 2016-2025
  • Figure 66 : Europe Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by Country, 2017 & 2025
  • Figure 67 : Europe Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by Country, 2016�2025
  • Figure 68 : Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2011�2016
  • Figure 69 : Europe Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2016�2025
  • Figure 70 : Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2011�2016
  • Figure 71 : Europe Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2016�2025
  • Figure 72 : Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2011�2016
  • Figure 73 : Europe Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2016�2025
  • Figure 74 : Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2011�2016
  • Figure 75 : Europe Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2016�2025
  • Figure 76 : Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2011�2016
  • Figure 77 : Europe Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2016�2025
  • Figure 78 : Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2011�2016
  • Figure 79 : Europe Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2016�2025
  • Figure 80 : Europe Active Pharmaceutical Ingredients Market Attractiveness Index, 2016-2025
  • Figure 81 : Asia Pacific Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by Country, 2017 & 2025
  • Figure 82 : Asia Pacific Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by Country, 2016�2025
  • Figure 83 : Asia Pacific Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2011�2016
  • Figure 84 : Asia Pacific Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2016�2025
  • Figure 85 : Asia Pacific Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2011�2016
  • Figure 86 : Asia Pacific Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2016�2025
  • Figure 87 : Asia Pacific Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2011�2016
  • Figure 88 : Asia Pacific Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2016�2025
  • Figure 89 : Asia Pacific Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2011�2016
  • Figure 90 : Asia Pacific Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2016�2025
  • Figure 91 : Asia Pacific Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2011�2016
  • Figure 92 : Asia Pacific Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2016�2025
  • Figure 93 : Asia Pacific Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2011�2016
  • Figure 94 : Asia Pacific Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2016�2025
  • Figure 95 : Asia Pacific Active Pharmaceutical Ingredients Market Attractiveness Index, 2016-2025
  • Figure 96 : Rest of World Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by Country, 2016 & 2025
  • Figure 97 : Rest of World Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by Country, 2016�2025
  • Figure 98 : Rest of World Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2011�2016
  • Figure 99 : Rest of World Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2016�2025
  • Figure 100 : Rest of World Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2011�2016
  • Figure 101 : Rest of World Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2016�2025
  • Figure 102 : Rest of World Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2011�2016
  • Figure 103 : Rest of World Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2016�2025
  • Figure 104 : Rest of World Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2011�2016
  • Figure 105 : Rest of World Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2016�2025
  • Figure 106 : Rest of World Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2011�2016
  • Figure 107 : Rest of World Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2016�2025
  • Figure 108 : Rest of World Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2011�2016
  • Figure 109 : Rest of World Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2016�2025
  • Figure 110 : Rest of World Active Pharmaceutical Ingredients Market Attractiveness Index, 2016-2025

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report